Catalyst Wire Dossier Catalyst Wire Dossier

Investigational monovalent HPV vaccine (unspecified type)

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational monovalent HPV vaccine (unspecified type), covering 2017-03-22 to 2017-03-22. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED) [Phase 3]

See pricing